SEC ownership of LeonaBio, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001620463.

Comparable stake leader

PERCEPTIVE ADVISORS LLC

Disclosed value leader

PERCEPTIVE ADVISORS LLC

Comparable rows

43/50

Latest evidence

23 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
43 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
PERCEPTIVE ADVISORS LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
23 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001620463
Issuer location
Bothell, WA

Ownership snapshot

Top shareholders of LeonaBio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
43/50
Latest evidence
23 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 20% 7 rows are not safely comparable across share classes. 13D/G row: PERCEPTIVE ADVISORS LLC Showing 1-8 of 50 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 20%.

43 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
PERCEPTIVE ADVISORS LLC 20%
ADAR1 Capital Management, LLC 7.7%
ACORN BIOVENTURES, L.P. 6.2%
Steven Michael Oliveira 4.1%
Baselake Partners, LP 1.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F 13D/G 3/4/5
Company · Director, 10%+ Owner
20%
from 13D/G
$19,113,830
1,859,322 shares
31 Mar 2026
ADAR1 Capital Management, LLC
13F 13D/G
Company
7.7%
from 13D/G
$7,478,505
727,481 shares
31 Mar 2026
ACORN BIOVENTURES, L.P.
13D/G
Anders Hove
6.2%
$1,345,504
596,068 shares
+$212,929 06 Jan 2026
Steven Michael Oliveira
13D/G
Oliveira Steven Michael
4.1%
$69,324
161,218 shares
-$788,375 01 Oct 2025
Baselake Partners, LP
13D/G
1.9%
$573,723
75,789 shares
-$921,208 31 Dec 2025
ACORN CAPITAL ADVISORS, LLC
13F
Company
13F
6.7%
$6,523,061
634,539 shares
31 Mar 2026
Commodore Capital LP
13F
Company
13F
4.9%
$4,774,011
464,398 shares
31 Mar 2026
NEA Management Company, LLC
13F
Company
13F
4.9%
$4,774,011
464,398 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$99,418.

Buys
$0
Insiders: 0
Sells
$99,418
Insiders: 5
Net
-$99,418
Shares: -16,748
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 16,748
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 10,469 $0 $56,219 -$56,219
6-9 0 6,279 $0 $43,200 -$43,200
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 22 reporting-owner rows connected to LeonaBio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
22
Largest Forms 3/4/5 holder
PERCEPTIVE ADVISORS LLC
Net 12M change
-$99,418
Latest report
23 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
PERCEPTIVE ADVISORS LLC Director, 10%+ Owner $17,718,931 Mixed 23 Jun 2026
Mark James Litton PRESIDENT and CEO, Director $445,121 -$45,479 -9.3% Mixed 09 Apr 2026
Hans Moebius Chief Medical Officer $266,213 Mixed 04 Jan 2024
Kelly A. Romano Director $194,951 Filing P/S 23 Jun 2026
Kevin Church Chief Scientific Officer $168,112 -$13,325 -7.3% Mixed 09 Apr 2026
Mark Worthington GENERAL COUNSEL and CCO $130,855 -$13,158 -9.1% Mixed 09 Apr 2026
Javier San Martin Chief Medical Officer $126,995 -$20,547 -14% Mixed 09 Apr 2026
Robert Renninger Chief Financial Officer $107,033 -$6,909 -6.1% Mixed 09 Apr 2026
Andrew Gengos CFO and Chief Business Officer $55,203 Filing P/S 03 Sep 2024
Rachel Lenington COO and CDO $11,812 Filing P/S 03 Sep 2024
Glenna Mileson Chief Financial Officer Mixed 19 Jan 2023
Tadataka Yamada Director Mixed 28 May 2021
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Director, 10%+ Owner Mixed 23 Jun 2026
Grant Pickering Director Mixed 23 Jun 2026
Joseph Edelman Director, 10%+ Owner Mixed 23 Jun 2026
Michael A. Panzara Director Mixed 23 Jun 2026
Barbara Kosacz Director Mixed 23 Jun 2026
John M. Fluke Jr. Director Mixed 09 Apr 2026
James A. Johnson Director Mixed 23 Jun 2026
Fred P. Callori Director Mixed 23 Jun 2026

Recent insider transactions for LeonaBio, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Perceptive Advisors Llc LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 See footnote
PERCEPTIVE ADVISORS LLC LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 See footnote
Perceptive Advisors Llc LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 See footnote
Fred P. Callori LONA Stock Option (Right to Buy) Award 2,333 2,333 23 Jun 2026 Direct
Natalie C. Holles LONA Stock Option (Right to Buy) Award 2,333 2,333 23 Jun 2026 Direct
Peter B. Silverman LONA Stock Option (Right to Buy) Award 2,333 2,333 23 Jun 2026 Direct
Michael A. Panzara LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
Kelly A. Romano LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
Joseph Edelman LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
James A. Johnson LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
Barbara Kosacz LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
Grant Pickering LONA Stock Option (Right to Buy) Award 28,000 28,000 23 Jun 2026 Direct
Natalie C. Holles LONA Stock Option (Right to Buy) Award 56,000 56,000 05 May 2026 Direct
Peter B. Silverman LONA Stock Option (Right to Buy) Award 56,000 56,000 05 May 2026 Direct
Fred P. Callori LONA Stock Option (Right to Buy) Award 56,000 56,000 05 May 2026 Direct
Perceptive Advisors Llc LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 See footnote
PERCEPTIVE ADVISORS LLC LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 See footnote
Perceptive Advisors Llc LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 See footnote
Michael A. Panzara LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Kevin Church LONA Stock Option (Right to Buy) Award 300,000 300,000 09 Apr 2026 Direct
Barbara Kosacz LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Grant Pickering LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Kelly A. Romano LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
James A. Johnson LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Joseph Edelman LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Javier San Martin LONA Stock Option (Right to Buy) Award 350,000 350,000 09 Apr 2026 Direct
John M. Fluke Jr. LONA Stock Option (Right to Buy) Award 28,000 28,000 09 Apr 2026 Direct
Mark Worthington LONA Stock Option (Right to Buy) Award 300,000 300,000 09 Apr 2026 Direct
Robert Renninger LONA Stock Option (Right to Buy) Award 300,000 300,000 09 Apr 2026 Direct
Mark James Litton LONA Stock Option (Right to Buy) Award 750,000 750,000 09 Apr 2026 Direct
Mark James Litton LONA Common Stock Sale -8.17% $27,688 $5.37 -5,156 57,926 04 Mar 2026 Direct
Robert Renninger LONA Common Stock Sale -5.41% $4,865 $5.37 -906 15,851 04 Mar 2026 Direct
Mark Worthington LONA Common Stock Sale -6.74% $7,131 $5.37 -1,328 18,376 04 Mar 2026 Direct
Kevin Church LONA Common Stock Sale -5.12% $7,298 $5.37 -1,359 25,178 04 Mar 2026 Direct
Javier San Martin LONA Common Stock Sale -9.77% $9,236 $5.37 -1,720 15,887 04 Mar 2026 Direct
Mark James Litton LONA Common Stock Options Exercise 54.5% 22,254 63,082 03 Mar 2026 Direct
Mark James Litton LONA Restricted Stock Units Options Exercise -100% -22,254 0 03 Mar 2026 Direct
Robert Renninger LONA Common Stock Options Exercise 30.3% 3,900 16,757 03 Mar 2026 Direct
Robert Renninger LONA Restricted Stock Units Options Exercise -100% -3,900 0 03 Mar 2026 Direct
Mark Worthington LONA Common Stock Options Exercise 41% 5,726 19,704 03 Mar 2026 Direct
Mark Worthington LONA Restricted Stock Units Options Exercise -100% -5,726 0 03 Mar 2026 Direct
Kevin Church LONA Common Stock Options Exercise 28.3% 5,856 26,537 03 Mar 2026 Direct
Kevin Church LONA Restricted Stock Units Options Exercise -100% -5,856 0 03 Mar 2026 Direct
Javier San Martin LONA Common Stock Options Exercise 72.8% 7,418 17,607 03 Mar 2026 Direct
Javier San Martin LONA Restricted Stock Units Options Exercise -100% -7,418 0 03 Mar 2026 Direct
Javier San Martin ATHA Common Stock Sale -13.9% $11,311 $6.88 -1,644 10,189 02 Jan 2026 Direct
Mark James Litton ATHA Common Stock Sale -5.96% $17,792 $6.88 -2,586 40,828 02 Jan 2026 Direct
Robert Renninger ATHA Common Stock Sale -2.26% $2,043 $6.88 -297 12,857 02 Jan 2026 Direct
Kevin Church ATHA Common Stock Sale -4.06% $6,027 $6.88 -876 20,681 02 Jan 2026 Direct
Mark Worthington ATHA Common Stock Sale -5.9% $6,027 $6.88 -876 13,978 02 Jan 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .